CDT Equity Inc. (CDT) vs Moolec Science SA (MLEC)

CDT Equity Inc. and Moolec Science SA are both Biotechnology companies. Moolec Science SA is the larger, with a market value of $620.0K against $390.0K — 1.6× the size. CDT Equity Inc. has the higher net margin (0.00% vs −105.7%) and the lower return on invested capital (−21.3% vs 0.00%). Across the 12 metrics below, Moolec Science SA leads on 8 and CDT Equity Inc. on 4.

Valuation

Metric CDT MLEC Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.03 9.40
P/B 0.00 0.01 2.13
Price to free cash flow n/m 0.01 25.18
EV/EBITDA n/m 1.76 0.66
EV/Sales n/m 8.37 9.02
Earnings yield (10,527,125.00%) (3,822.12%) (32.88%)
Free cash flow yield (43,606.95%) 8,301.70% (23.13%)

Profitability

Metric CDT MLEC Biotechnology median
Gross margin — 2,373.25% 68.51%
Operating margin 0.00% 244.93% 0.00%
Net margin 0.00% (105.71%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (69.68%) 0.00% (51.96%)
Return on assets (55.16%) 0.00% (46.06%)
Return on invested capital (21.28%) 0.00% 0.00%

Growth

Metric CDT MLEC Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 98.09% (793.17%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CDT MLEC Biotechnology median
Debt to equity 0.00 4.37 0.00
Current ratio 0.13 0.15 4.97
Net debt to EBITDA 0.05 (2.73) 1.01

Dividend

Metric CDT MLEC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CDT MLEC Biotechnology median
Market cap 390.00k 620.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack